| Website | indeltherapeutics... |
| Category | BioTech |
| Phone | (604) 551-8464 |
| info@indelrx.com | |
| Employees |
| TOTAL | $1.4M |
| FUNDING TOTAL | $1.4M |
| Series B, 4/11 Morningside Venture Investments MAD Ventures Quantum Pacific Capital | $1.4M |
Indel Therapeutics Inc. is a Vancouverâ€based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company has a growing pipeline of novel antibiotic drug discovery programs focused on curing difficultâ€toâ€treat and hospitalâ€acquired infections. These programs are based on Indel’s paradigmâ€changing antimicrobial drug discovery platform, a patented technology that that has opened a rich, new area of antimicrobial drug targets for the treatment of infectious diseases and has the potential to provide an advantage against drug resistance.
